Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children

Completed · Phase 3

Conditions studied: Agitation, Anesthesia, Pediatrics

In brief

Emergence delirium (ED) from general anesthesia posts risk and harm to pediatric population undergo general anesthesia. The purpose of the study is to compare the use of dexmedetomidine versus placebo in reducing the incidence and severity of ED in a pediatric neurosurgical population.

Key facts

Study ID

NCT00857727

Run by

St. Luke's-Roosevelt Hospital Center

People needed

33

Starts

2009-08-01

Expected to finish

2011-12-01

Last updated by the study team

2018-11-27

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children age 6 months through 17 years of age undergoing interventional neuroradiologic procedures at our hospital under general anesthesia
• Patients classify as an ASA (American Society of Anesthesiologists) I-III
• Have not received anesthetic for over 30 days from previous procedures

You may not qualify if…

• Receiving digoxin therapy from the study
• Severe congestive heart failure or pulmonary hypertension requiring vasodilators
• Disease processes other than that associated with their intracranial pathology, such as hepatic or renal dysfunction

Where it is running

• St Luke's-Roosevelt Hospital Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.